Literature DB >> 1404825

Tacrine for treating Alzheimer's disease.

G W Small.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1992        PMID： 1404825

Source DB:  PubMed          Journal:  JAMA        ISSN： 0098-7484            Impact factor:   56.272


× No keyword cloud information.
  5 in total

Review 1.  The cost of Alzheimer's disease. Will drug treatment ease the burden?

Authors:  W Max
Journal:  Pharmacoeconomics       Date:  1996-01       Impact factor: 4.981

2.  Response surface methodology to investigate the iontophoretic delivery of tacrine hydrochloride.

Authors:  Rashmi S Upasani; Ajay K Banga
Journal:  Pharm Res       Date:  2004-12       Impact factor: 4.200

Review 3.  Clinical pharmacokinetics of tacrine.

Authors:  S Madden; V Spaldin; B K Park
Journal:  Clin Pharmacokinet       Date:  1995-06       Impact factor: 6.447

Review 4.  Tacrine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in Alzheimer's disease.

Authors:  A J Wagstaff; D McTavish
Journal:  Drugs Aging       Date:  1994-06       Impact factor: 3.923

5.  Late-Stage Modification of Medicine: Pd-Catalyzed Direct Synthesis and Biological Evaluation of N-Aryltacrine Derivatives.

Authors:  Lin-Xi Wan; Yong-Qi Zhen; Zhen-Xiang He; Yang Zhang; Lan Zhang; Xiaohuan Li; Feng Gao; Xian-Li Zhou
Journal:  ACS Omega       Date:  2021-04-02
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.